|1.||Suno, Manabu: 1 article (10/2012)|
|2.||Chuang, Victor Tuan Giam: 1 article (10/2012)|
|3.||Miyagishima, Takuto: 1 article (01/2010)|
|4.||Kunieda, Yasuyuki: 1 article (01/2010)|
|5.||Fuse, Nozomu: 1 article (01/2010)|
|6.||Wakahama, Osamu: 1 article (01/2010)|
|7.||Tateyama, Miki: 1 article (01/2010)|
|8.||Komatsu, Yoshito: 1 article (01/2010)|
|9.||Sakata, Yu: 1 article (01/2010)|
|10.||Yuuki, Satoshi: 1 article (01/2010)|
|1.||Colorectal Neoplasms (Colorectal Cancer)
10/01/2012 - "Six randomized Phase 3 clinical studies demonstrated the safety and efficacy of levoleucovorin as a modulator of fluorouracil in combination with/without other antitumor agents in colorectal cancer patients. "
01/01/2010 - "Modified-irinotecan/fluorouracil/levoleucovorin therapy as ambulatory treatment for metastatic colorectal cancer: results of phase I and II studies."
01/01/2010 - "Combined therapy with irinotecan/fluorouracil/levoleucovorin (calcium levofolinate) [IFL] has lost its position as the standard regimen for metastatic colorectal cancer because its toxicity and effectiveness have become controversial. "
10/01/2012 - "Levoleucovorin has been studied in other cancers. "
10/01/2012 - "To comprehensively review the literature regarding the efficacy, safety, and costs associated with the use of levoleucovorin in cancer treatment and to assess whether levoleucovorin would be a reasonable alternative to the use of racemic leucovorin. "
10/01/2012 - "Levoleucovorin as replacement for leucovorin in cancer treatment."
|2.||Antineoplastic Agents (Antineoplastics)
|4.||Leucovorin (Folinic Acid)